Evidence map›Paper›PMID 28158302›Full record

ArticlePLoS pathogens2017

Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury.

Martina Bielaszewska, Christian Rüter, Andreas Bauwens, Lilo Greune, Kevin-André Jarosch, Daniel Steil, Wenlan Zhang, Xiaohua He, Roland Lloubes, Angelika Fruth and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 230 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Effect of gut bacterial extracellular vesicles on angiogenic potential and vascular integrity: positive and negative aspects.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Frontiers in veterinary science · 2026
    Article
  15. TM9SF4 acts as a receptor mediatingFrontiers in cellular and infection microbiology · 2026
    Article
  16. Article
  17. Article
  18. Predicting clinical outcome ofMicrobial genomics · 2025
    Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Martina BielaszewskaInstitute of Hygiene, University of Münster, Münster, Germany.ORCID 0000-0002-1226-7066
Christian RüterInstitute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
Andreas BauwensInstitute of Hygiene, University of Münster, Münster, Germany.
Lilo GreuneInstitute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
Kevin-André JaroschInstitute of Hygiene, University of Münster, Münster, Germany.
Daniel SteilInstitute of Hygiene, University of Münster, Münster, Germany.
Wenlan ZhangInstitute of Hygiene, University of Münster, Münster, Germany.
Xiaohua HeWestern Regional Research Center, Agricultural Research Service, United States Department of Agriculture (USDA), Albany, California, United States of America.
Roland LloubesLaboratoire d'Ingenierie des Systemes Macromoleculaires UMR7255, CNRS-Aix-Marseille Université, Marseille, France.
Angelika FruthNational Reference Center for Salmonella and Other Enteric Pathogens, Robert Koch Institute, Branch Wernigerode, Wernigerode, Germany.
Kwang Sik KimDivision of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
M Alexander SchmidtInstitute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.
Ulrich DobrindtInstitute of Hygiene, University of Münster, Münster, Germany.
Alexander MellmannInstitute of Hygiene, University of Münster, Münster, Germany.
Helge KarchInstitute of Hygiene, University of Münster, Münster, Germany.
University of Münster · DEAgricultural Research Service · USCentre National de la Recherche Scientifique · FRJohns Hopkins University · USRobert Koch Institute · DE

Funding

E. coli penetration of the blood-brain barrierR21AI113273 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KIM, KWANG S · 2016 to 2017
$446k
Bacterial penetration of the blood-brain barrierR21AI114925 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KIM, KWANG S · 2015 to 2016
$446k
NIAID NIH HHS R21 AI113273NIAID NIH HHS R21 AI114925
6 · The paper itself

Abstract

Outer membrane vesicles (OMVs) are important tools in bacterial virulence but their role in the pathogenesis of infections caused by enterohemorrhagic Escherichia coli (EHEC) O157, the leading cause of life-threatening hemolytic uremic syndrome, is poorly understood. Using proteomics, electron and confocal laser scanning microscopy, immunoblotting, and bioassays, we investigated OMVs secreted by EHEC O157 clinical isolates for virulence factors cargoes, interactions with pathogenetically relevant human cells, and mechanisms of cell injury. We demonstrate that O157 OMVs carry a cocktail of key virulence factors of EHEC O157 including Shiga toxin 2a (Stx2a), cytolethal distending toxin V (CdtV), EHEC hemolysin, and flagellin. The toxins are internalized by cells via dynamin-dependent endocytosis of OMVs and differentially separate from vesicles during intracellular trafficking. Stx2a and CdtV-B, the DNase-like CdtV subunit, separate from OMVs in early endosomes. Stx2a is trafficked, in association with its receptor globotriaosylceramide within detergent-resistant membranes, to the Golgi complex and the endoplasmic reticulum from where the catalytic Stx2a A1 fragment is translocated to the cytosol. CdtV-B is, after its retrograde transport to the endoplasmic reticulum, translocated to the nucleus to reach DNA. CdtV-A and CdtV-C subunits remain OMV-associated and are sorted with OMVs to lysosomes. EHEC hemolysin separates from OMVs in lysosomes and targets mitochondria. The OMV-delivered CdtV-B causes cellular DNA damage, which activates DNA damage responses leading to G2 cell cycle arrest. The arrested cells ultimately die of apoptosis induced by Stx2a and CdtV via caspase-9 activation. By demonstrating that naturally secreted EHEC O157 OMVs carry and deliver into cells a cocktail of biologically active virulence factors, thereby causing cell death, and by performing first comprehensive analysis of intracellular trafficking of OMVs and OMV-delivered virulence factors, we provide new insights into the pathogenesis of EHEC O157 infections. Our data have implications for considering O157 OMVs as vaccine candidates.

Indexed as

Bacterial Outer Membrane ProteinsCells, CulturedEnzyme-Linked Immunosorbent AssayEscherichia coli InfectionsEscherichia coli O157Host-Pathogen InteractionsHumansImmunoblottingMicroscopy, Electron, TransmissionProtein TransportTransport VesiclesVirulenceVirulence FactorsBacterial Outer Membrane ProteinsVirulence Factors

Identifiers

PMID28158302
PMCPMC5310930
OpenAlexW2585531756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.